Antileukemic effect of L-aspartyl-hydrazine.

Abstract	Beta-L-aspartyl-hydrazine can significantly prolong survival of the A mouse strain infected with a lymphatic leukemia sensitive to L-asparaginase. By combining the above substance with L-asparaginase even better results can be obtained.
Authors	P Stern, K Valjevac, K Balenović
Journal	Neoplasma (Neoplasma) Vol. 22 Issue 1 Pg. 69-71 ( 1975) ISSN: 0028-2685 [Print] Slovakia
PMID	1153038 (Publication Type: Journal Article)
Chemical References	Hydrazines beta-L-aspartyl-hydrazine Aspartic Acid Asparaginase
Topics	Animals Asparaginase (administration & dosage, therapeutic use) Aspartic Acid (administration & dosage, analogs & derivatives, therapeutic use) Carcinoma, Ehrlich Tumor (drug therapy) Hydrazines (administration & dosage, therapeutic use) Leukemia, Experimental Leukemia, Lymphoid (drug therapy) Mice Sarcoma 180 (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!